Tarsus Pharmaceuticals, Inc. ( TARS) - Stock Earnings
TARS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
TARS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -8.4 million USD | 151.7 million USD |
| 2026Q1 | -7.0 million USD | 162.1 million USD |
| 2026Q2 | -18.6 million USD | 173.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TARS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -135.9 million USD | 17.4 million USD |
| 2024 | -115.6 million USD | 183.0 million USD |
| 2025 | -66.4 million USD | 451.4 million USD |
| 2026 Est. | — | — |
TARS
Price: $68.07
52 week price:
Earnings Per Share: -1.08 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 37491
Market Capitalization: 3.1 billion